119 related articles for article (PubMed ID: 35139734)
1. Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of
Wang CJ; Jia MZ; Deng LP; Li WJ; Zhang Q; Zhang TJ; Li SY; Cui L; Li ZG
Pediatr Hematol Oncol; 2022 Sep; 39(6):549-560. PubMed ID: 35139734
[TBL] [Abstract][Full Text] [Related]
2. Low expression of
Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
[TBL] [Abstract][Full Text] [Related]
3. Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia.
Juárez-Velázquez R; Reyes-León A; Salas-Labadía C; Rivera-Luna R; Velasco-Hidalgo L; López-Hernández G; López-Santiago N; Paredes-Aguilera R; Domínguez-López A; Bernáldez R; Pérez-Vera P
Leuk Lymphoma; 2014 Oct; 55(10):2305-11. PubMed ID: 24397596
[TBL] [Abstract][Full Text] [Related]
4. Interaction of E2F3a and CASP8AP2 Regulates Histone Expression and Chemosensitivity of Leukemic Cells.
Jin FF; Wang CJ; Cui L; Liu FF; Wang KL; Li WJ; Li ZG
J Pediatr Hematol Oncol; 2023 Apr; 45(3):e339-e344. PubMed ID: 36162009
[TBL] [Abstract][Full Text] [Related]
5. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2.
Flotho C; Coustan-Smith E; Pei D; Iwamoto S; Song G; Cheng C; Pui CH; Downing JR; Campana D
Blood; 2006 Aug; 108(3):1050-7. PubMed ID: 16627760
[TBL] [Abstract][Full Text] [Related]
6. CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia.
Jiao Y; Cui L; Gao C; Li W; Zhao X; Liu S; Wu M; Deng G; Li Z
Leuk Res; 2012 Jan; 36(1):67-71. PubMed ID: 21696825
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia.
Li ZG; Jiao Y; Li WJ; Deng GR; Cui L; Gao C; Zhao XX; Wu MY; Jia HT
Leuk Res; 2013 Oct; 37(10):1287-93. PubMed ID: 23953914
[TBL] [Abstract][Full Text] [Related]
8. Interaction of ZEB and histone deacetylase with the PLDLS-binding cleft region of monomeric C-terminal binding protein 2.
Zhao LJ; Kuppuswamy M; Vijayalingam S; Chinnadurai G
BMC Mol Biol; 2009 Sep; 10():89. PubMed ID: 19754958
[TBL] [Abstract][Full Text] [Related]
9. Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol.
Cui L; Gao C; Zhang RD; Jiao Y; Li WJ; Zhao XX; Liu SG; Yue ZX; Zheng HY; Deng GR; Wu MY; Li ZG; Jia HT
Leuk Res; 2015 Feb; 39(2):115-23. PubMed ID: 25530566
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress regulates the intestinal stem cell state through CtBP2.
Meijer BJ; Smit WL; Koelink PJ; Westendorp BF; de Boer RJ; van der Meer JHM; Vermeulen JLM; Paton JC; Paton AW; Qin J; Dekker E; Muncan V; van den Brink GR; Heijmans J
Sci Rep; 2021 May; 11(1):9892. PubMed ID: 33972635
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional co-repressor CtBP2 orchestrates epithelial-mesenchymal transition through a novel transcriptional holocomplex with OCT1.
Ma Y; Sekiya M; Kainoh K; Matsuda T; Iwasaki H; Osaki Y; Sugano Y; Suzuki H; Takeuchi Y; Miyamoto T; Yahagi N; Nakagawa Y; Matsuzaka T; Shimano H
Biochem Biophys Res Commun; 2020 Mar; 523(2):354-360. PubMed ID: 31866012
[TBL] [Abstract][Full Text] [Related]
13. Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
Gao C; Liu SG; Lu WT; Yue ZX; Zhao XX; Xing TY; Chen ZP; Zheng HY; Li ZG
Mol Med Rep; 2020 Oct; 22(4):2905-2915. PubMed ID: 32945392
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2.
May T; Yang J; Shoni M; Liu S; He H; Gali R; Ng SK; Crum C; Berkowitz RS; Ng SW
Neoplasia; 2013 Jun; 15(6):600-8. PubMed ID: 23730208
[TBL] [Abstract][Full Text] [Related]
15. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
Katsuyama E; Yan M; Watanabe KS; Narazaki M; Matsushima S; Yamamura Y; Hiramatsu S; Ohashi K; Watanabe H; Katsuyama T; Zeggar S; Yoshida N; Moulton VR; Tsokos GC; Sada KE; Wada J
J Immunol; 2017 Jun; 198(11):4268-4276. PubMed ID: 28438897
[TBL] [Abstract][Full Text] [Related]
17. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
18. Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells.
Hummon AB; Pitt JJ; Camps J; Emons G; Skube SB; Huppi K; Jones TL; Beissbarth T; Kramer F; Grade M; Difilippantonio MJ; Ried T; Caplen NJ
Mol Cancer; 2012 Jan; 11():1. PubMed ID: 22216762
[TBL] [Abstract][Full Text] [Related]
19. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia.
Erbilgin Y; Hatirnaz Ng O; Can I; Firtina S; Kucukcankurt F; Karaman S; Karakas Z; Celkan TT; Zengin E; Aylan Gelen S; Nihal Ozdemir G; Yildirmak Y; Dogru O; Tansel T; Khodzhaev K; Toluk O; Ozbek U; Sayitoglu M
Int J Lab Hematol; 2021 Oct; 43(5):1093-1103. PubMed ID: 33844466
[TBL] [Abstract][Full Text] [Related]
20. ZEB2 in T-cells and T-ALL.
De Coninck S; Berx G; Taghon T; Van Vlierberghe P; Goossens S
Adv Biol Regul; 2019 Dec; 74():100639. PubMed ID: 31383581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
